Record Grosses, Thinner Rooms: The 2026 Touring Math
The top 100 tours grossed more than ever in the first half of 2026 while selling fewer tickets per night, and the new ticket laws mostly target resale.
The headline number from Pollstar's 2026 mid-year report looks like a boom. The top 100 touring artists grossed $3.16 billion worldwide between Nov. 13, 2025 and May 13, 2026, up 12.3% on the same window last year, on 26.3 million tickets, up 12.8%, according to Pollstar. Underneath that total, the business is working harder for each dollar.
More shows, smaller nights
The growth came from volume. Pollstar counted 18.2% more shows from the top 100 than a year earlier. Per show, almost every measure went down. The average gross per show fell 5% to $1.63 million. Average tickets per show fell 4.6% to 13,574. The worldwide average ticket price slipped to $119.92 from $120.43, and only 11 stadium tours were running at mid-year, down from 18 in 2025, per the same report.
North America is flatter still. Gross for the region was $1.923 billion against $1.921 billion a year earlier, a 0.1% rise, while shows rose 8.6%. Average gross per show in North America fell 7.8% to about $1.14 million, and the average ticket price dropped 2.4% to $122.15. Pollstar's own reading is that domestic revenue may be near a ceiling.
That matters because price, not attendance, drove the last few years of growth. IBISWorld puts the North American top-100 average at $91.86 in 2019 and a peak of $132.18 in 2024, in a September analysis. Prices have now stopped rising, and the industry has responded by booking more dates rather than charging more per seat.
The middle carries the risk
Averages hide where the pressure sits. Pollstar's report names "Blue Dot Fever," the unsold seats that show up as blue dots on seating maps, and says it hits hardest for acts without a major recent hit or a top album. The same report notes that many mid-tier and smaller venues are struggling and that some artists are leaving the road, citing costs they can no longer cover.
The arithmetic for those acts is simple. A headliner with a stadium draw can spread a fixed production budget across 50,000 seats. A theater act carries the same bus, fuel, and crew costs into a room of 2,000. IBISWorld cites the indie band Los Campesinos!, which reported that 45% of a 2024 tour budget went to a sleeper bus, fuel and driver wages, and 18.3% to crew wages. When ticket prices flatten and costs keep rising, the squeeze lands on the act in the middle.
The independent venue trade group felt it too. The program for NIVA '26 in Minneapolis in June included a session on the "skyrocketing costs of touring," Hypebot reported, alongside a session on resale price cap laws.
Regulation is aimed at resale
The policy response in 2026 has focused on the secondary market, not the face price.
- California. Gov. Gavin Newsom signed AB 1349 in September, banning the sale of "ghost tickets" a seller does not yet own, CalMatters reported. A separate bill with a 10% resale markup cap stalled in August. CalMatters also reported that StubHub spent $4.4 million lobbying across the two-year session.
- Massachusetts. Gov. Maura Healey proposed in July to cap resale at 110% of face value and limit reseller fees to 10% of the total price, according to WBUR.
- United Kingdom. The government said in November 2025 it would ban resale above face value, with the Competition and Markets Authority enforcing, Music Business Worldwide reported.
None of these touches dynamic or "platinum" pricing in the primary sale. WBUR quoted the Ticket Policy Forum's Brian Berry making exactly that criticism of the Massachusetts plan, noting that primary sales in the state run mostly through Ticketmaster, the subject of an April 2026 jury verdict finding an illegal monopoly. The governor's office answered that artists and promoters set primary prices and that it would keep evaluating protections there.
Capping resale moves margin back to the primary seller. It does not lower the face price.
What to watch
A resale cap shifts money from brokers back toward the artist and promoter, which sounds like good news for touring acts. It only helps the middle if those acts can sell out the room in the first place. The 2026 numbers say the top of the market can still fill more dates. The question for the next Pollstar year-end report is whether more shows at flat prices is a strategy or a symptom.